Dr. Daly has a clinical focus on the treatment of thoracic malignancies, lymphoma, and head and neck cancers. She specializes in a variety of radiotherapy techniques including stereotactic body radiotherapy (SBRT), intensity modulated radiation therapy (IMRT), and image guided radiation therapy (IGRT).
Dr. Daly’s research interests focus on the use of stereotactic body radiotherapy for the treatment of early-stage lung cancer, metastatic lesions to the lung, and for primary and metastatic tumors of the spine. She also has a research interest in head and neck cancer, specifically in the use of advances in image guidance and conformal treatments to allow dose escalation while sparing normal tissues and reducing the side-effect profile of radiation treatment.
Philosophy of Care
I believe in treating cancer aggressively while maintaining my patients’ quality of life and well-being. I feel that cancer treatment is a partnership between each patient and the team of specialists providing care. My goal is for my patients to fully understand all treatment options and to feel completely comfortable with their treatment decisions.
4501 X St.
Sacramento, CA 95817
B.S., Stanford University, Stanford, California, 2001
American Society for Therapeutic Radiology and Oncology (ASTRO)
International Association for the Study of Lung Cancer (IASLC)
Select Honors and Awards:
RNSA Roentgen Resident/Fellow Research Award, 2011
AAWR Member-in-Training Award for Outstanding ASTRO Presentation, 2009
Arnold P. Gold Foundation Humanism and Excellence in Teaching Award-Stanford Medical School, 2009
Stanford Medical Scholars grant recipient, 2003
Fight for Sight Research Fellow, 1999
National Merit Scholar, 1997
Select Recent Publications:
Daly ME*, Luxton G*, Choi CYH, Gibbs IC, Chang SD, Adler JR, Soltys SG. Normal tissue complication probability estimation by the Lyman-Kutcher-Berman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2011 April 29. [Epub ahead of print]
Daly ME, Choi CYH, Gibbs IC, Lieberson RE, Adler JA, Chang SD, Soltys SG. Tolerance of the spinal cord to stereotactic radiosurgery: Insights from hemangioblastomas. Int J Radiat Oncol Biol Phys 2011 May1; 80(1):213-220.
Daly ME, Le QT, Jain A, Maxim PG, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Colevas AD, Pinto HA, Chang DT. Intensity modulated radiotherapy for locally advanced cancers of the hypopharynx and larynx. Head Neck 2011 Jan; 33(1): 103-11. [Epub ahead of print]
Daly ME, Le QT, Kozak M, Maxim PG, Murphy JD, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Chang DT. Intensity modulated radiotherapy for oral cavity squamous cell carcinoma: Patterns of failure and predictors of local control. Int J Radiat Oncol Biol Phys 2011 Aug 1; 80(5):1912-22. [Epub ahead of print]
Daly ME, Murphy JD, Mok E, Christman-Skiller C, Koong AC, Chang DT. Rectal and bladder deformation and displacement during pre-operative radiotherapy for rectal cancer: Are current contouring guidelines adequate for conformal therapy? Practical Radiation Oncology 2011 April-June; 1(2): 85-94.
Murphy JD, Chang DT, Abelson J, Daly ME, Yeung HN, Nelson LM, Koong AC. Cost effectiveness of radiotherapy in locally advanced pancreatic cancer. Cancer 2011 July 19 [Epub ahead of print]
Murphy JD, Chisholm KM, Daly ME, Wiegner EA, Truong D, Iagaru A, Maxim PG, Loo BW, Graves EE, Kaplan MJ, Kong C, Le QT. Correlation between metabolic tumor volume and pathologic tumor volume in head and neck cancer. Radiother Oncol. 2011 Dec; 101(3): 356-61. [Epub ahead of print]
Daly ME, Le QT, Maxim PG, Loo BW, Kaplan MK, Fischbein NJ, Pinto H, Chang DT. Intensity-modulated radiotherapy for oropharyngeal carcinoma: Clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010 Apr; 76(5):1339-46.
Daly ME and Horst KC. Locoregional management of breast cancer in women under 40. Breast Diseases: A Year Book Quarterly. 2010 Aug; 21(3):207-10.
Chen AM, Daly ME, El-Sayad I, Garcia J, Lee NY, Bucci MK, Kaplan MJ. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):338-343.
Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, Eisele DW. Intensity modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):151-7.
Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, Weinberg V, Garcia J, Lee NY, Kaplan MJ, El-Sayad E, Eisele DW, Fu KK, Philips TL. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: Are we making improvement? Int J Radiat Oncol Biol Phys. 2007 Sept 1; 69(1):141-7.
Daly ME, Lievskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WF, Koong A, Goffinet DR, Xing L, Le QT. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity-modulated radiotherapy for head and neck squamous cell carcinoma. Head Neck 2007 Mar; 29(3):211-20.